Ex Parte HASEBE et al - Page 5


                     Appeal No.  2003-1428                                                                       Page 5                        
                     Application No.  09/468,777                                                                                               

                             With respect to Nakamura and Dubief, Appellants argue that the                                                    
                     compositions taught by those references as present as an emulsion, in which the                                           
                     lipid exists as an anisotropic crystal phase in conjunction with the surfactant.                                          
                     See Appeal Brief, pages 4-8.  Thus, in the compositions taught by the Nakamura                                            
                     and Dubief, the lipid and surfactant are melted together to form a new liquid                                             
                     crystal phase:  In contrast, appellants assert that in the claimed composition the                                        
                     amphipathic lipid is present as a solid particulate which is dispersed in the                                             
                     surfactant, and if present, the aqueous phase.  See id.                                                                   
                             With respect to the rejection over Pillai, appellants argue that the                                              
                     “reference fails to disclose or suggest solid particles of amphipathic lipid in any                                       
                     context, the reference can not suggest a dispersion in which the amphipathic lipid                                        
                     is a solid particulate and dispersed in a surfactant and aqueous medium.”  Id. at                                         
                     9.                                                                                                                        
                             “In rejecting claims under 35 U.S.C. § 103, the examiner bears the initial                                        
                     burden of presenting a prima facie case of obviousness.  Only if that burden is                                           
                     met, does the burden of coming forward with evidence or argument shift to the                                             
                     applicant.”  In re Rijckaert, 9 F.3d 1531, 1532, 28 USPQ2d 1955, 1956 (Fed. Cir.                                          
                     1993) (citations omitted).  The test of obviousness is “whether the teachings of                                          
                     the prior art, taken as a whole, would have made obvious the claimed invention.”                                          
                     In re Gorman, 933 F.2d 982, 986, 18 USPQ2d 1885, 1888 (Fed. Cir. 1991).                                                   
                             We agree that the combinations based on Nakamura and Dubief do not                                                
                     teach a composition, “wherein said amphipathic lipid has an average particle size                                         
                     of 0.5 to 150 µm as a solid particulate,” see claim 11, or a composition                                                  





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007